🔎 Trials Near Me

Gara Jalqabaatti › Leukemia Lymphoblasticii Hamaa › Massachusetts › Boston

Qorannoo klinikaalii Leukemia Lymphoblasticii Hamaa Boston, MA keessatti

Qorannoo 15 Leukemia Lymphoblasticii Hamaa f Boston fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia

Namoota walitti qabaa jiraSadarkaa 1/2
  • Dana-Farber Cancer Institute, Boston
Umuriin 16 hanga 75 · Saalaa hunda · Haaromfame 10-Ful-2026 · NCT03104491

ALL Backbone in AYAs

Namoota walitti qabaa jiraSadarkaa 2
  • Dana Farber Cancer Institute, Boston
Umuriin 18 hanga 51 · Saalaa hunda · Haaromfame 17-Hag-2026 · NCT07227584

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Children's Hospital Corporation d/b/a Boston Children's Hospital, Boston
1 Day – 17 Years · Saalaa hunda · Haaromfame 14-Hag-2026 · NCT06274788

A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant

Namoota walitti qabaa jiraSadarkaa 1Hojjettoota fayyaa simatamoo
  • Brigham and Women's Hospital, Boston
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 28-Ado-2026 · NCT07020533

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Tufts Medical Center, Boston
  • Beth Israel Deaconess, Boston
  • Dana Farber Cancer Institute, Boston
Umuriin hundi · Saalaa hunda · Haaromfame 06-Ado-2026 · NCT01351545

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Dana-Farber Cancer Institute, Boston
Umuriin hundi · Saalaa hunda · Haaromfame 18-Cam-2026 · NCT01790152

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

Namoota walitti qabaa jiraSadarkaa 1
  • Dana Farber Cancer Institute, Boston
Umuriin 13 fi ol · Saalaa hunda · Haaromfame 05-Cam-2026 · NCT04771572

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

Namoota walitti qabaa jiraSadarkaa 1/2
  • Massachusetts General Hospital, Boston
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 24-Bit-2026 · NCT04988555

Venetoclax Basket Trial for High Risk Hematologic Malignancies

Namoota walitti qabaa jiraSadarkaa 1
  • Dana-Farber Cancer Institute, Boston
Umuriin 1 hanga 40 · Saalaa hunda · Haaromfame 12-Bit-2026 · NCT05292664

CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant

Namoota walitti qabaa jiraSadarkaa 2Hojjettoota fayyaa simatamoo
  • DFCI/BWH Brigham and Women's Hospital, Boston
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 10-Bit-2026 · NCT06059391

Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)

Namoota walitti qabaa jiraSadarkaa 1
  • Dana-Farber Cancer Institute, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Elb-2025 · NCT06462365

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Namoota walitti qabaa jiraSadarkaa 1
  • Dana-Farber Cancer Institute, Boston
Umuriin 1 hanga 21 · Saalaa hunda · Haaromfame 06-Mud-2024 · NCT05476770

Qorannoo Leukemia Lymphoblasticii Hamaa magaalota biroo keessatti

Qorannoo biroo Boston keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.